首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1390621

營運商篩選市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Carrier Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年11月24日 | 出版商:

IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

概要

2022年全球帶因者篩檢市場規模達17億美元。展望未來， IMARC Group預計到2028年市場規模將達到31億美元，2022-2028年複合年成長率（CAGR）為10.53%。

攜帶者篩檢是一種基因檢測技術，用於識別胎兒中可能導致體染色體隱性遺傳疾病的異常基因。它是一種預測性和症狀前測試解決方案，孕婦和夫婦使用它來分析孩子從父母那裡遺傳遺傳性疾病的風險。它涉及測試唾液、血液或臉頰組織樣本，以檢測是否存在囊性纖維化、鐮狀細胞性貧血和泰薩克斯症等疾病的異常基因。這些樣本透過基於脫氧核糖核酸 (DNA) 定序、聚合酶鍊式反應 (PCR) 和微陣列技術的分子和生化過程進行篩選。它們用於針對各種肺部、血液和神經系統疾病進行擴展、客製化面板、預先設計面板和目標疾病攜帶者篩檢。

營運商篩檢市場趨勢：

全球胎兒染色體異常和遺傳性疾病盛行率的增加是推動市場成長的關鍵因素之一。此外，大眾對早期發現和診斷疾病的好處的認知不斷提高，也推動了市場的成長。與此一致的是，分子篩檢測試被廣泛進行，以識別遺傳密碼中的DNA突變，並檢測可能導致心臟缺陷、白血病前期、聽力缺陷和唐氏症的突變。帶因者篩檢也有助於提供充分的產前和生殖護理，有助於遺傳性疾病的適當管理。此外，各種技術進步，例如用於遺傳疾病篩檢的下一代定序（NGS）技術的開發，也有利於市場成長。其他因素，包括生物技術和生物資訊學領域的廣泛研發（R＆D）活動，以及醫療基礎設施的顯著成長，預計將推動市場成長。

本報告回答的關鍵問題：

迄今為止，全球帶因者篩檢市場的表現如何？未來幾年將如何表現？
COVID-19 對全球帶因者篩檢市場有何影響？
主要區域市場有哪些？
依類型分類市場是怎麼樣的？
基於醫療狀況的市場區隔是什麼？
基於技術的市場區隔是什麼？
基於最終用戶的市場區隔是什麼？
產業價值鏈的各個階段是什麼？
該行業的關鍵促進因素和挑戰是什麼？
全球攜帶者篩檢市場的結構如何？誰是主要參與者？
產業競爭程度如何？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 11 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 14 章：價格分析

第15章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Fulgent Genetics
- Gene By Gene Ltd. (MyDNA)
- Illumina Inc.
- Invitae Corporation
- MedGenome Labs Ltd.
- Myriad Genetics Inc.
- Natera Inc.
- OPKO Health Inc.
- Quest Diagnostics
- Sema4
- Thermo Fisher Scientific Inc.

簡介目錄圖表

Product Code: SR112023A4417

Abstract

The global carrier screening market size reached US$ 1.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 10.53% during 2022-2028.

Carrier screening is a genetic testing technique used for the identification abnormal genes in fetuses that can cause autosomal recessive diseases. It is a predictive and pre-symptomatic testing solution used by pregnant individuals and couples to analyze the risks of their child inheriting genetic disorders from the parents. It involves testing a sample of saliva, blood or cheek tissue to detect the presence of an abnormal gene for disorders, such as cystic fibrosis, sickle cell anemia and Tay-Sachs disease. These samples are screened through molecular and biochemical processes based on deoxyribonucleic acid (DNA) sequencing, polymerase chain reaction (PCR) and microarray technologies. They are used for expanded, customized panel, predesigned panel and targeted disease carrier screening for various pulmonary, hematological and neurological disorders.

Carrier Screening Market Trends:

The increasing prevalence of fetal chromosomal abnormalities and genetic disorders across the globe is one of the key factors driving the growth of the market. Moreover, the rising consciousness among the masses regarding the benefits of early detection and diagnosis of diseases is providing a thrust to the market growth. In line with this, molecular screening tests are widely conducted to identify DNA mutations in the genetic codes and detect the mutations that can cause heart defects, pre-leukemia, hearing defects and down syndrome. Carrier screening also aids in providing adequate prenatal and reproductive care, which facilitates the proper management of heritable diseases. Additionally, various technological advancements, such as the development of next-generation sequencing (NGS) techniques for genetic disease screening, are also favoring the market growth. Other factors, including extensive research and development (R&D) activities in the field of biotechnology and bioinformatics, along with significant growth in the medical infrastructure, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global carrier screening market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, medical condition, technology and end user.

Breakup by Type:

Expanded Carrier Screening

Customized Panel Testing

Predesigned Panel Testing

Targeted Disease Carrier Screening

Breakup by Medical Condition:

Pulmonary Conditions

Hematological Conditions

Neurological Conditions

Others

Breakup by Technology:

DNA Sequencing

Polymerase Chain Reaction

Microarrays

Others

Breakup by End User:

Hospitals and Clinics

Reference Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Fulgent Genetics, Gene By Gene Ltd. (MyDNA), Illumina Inc., Invitae Corporation, MedGenome Labs Ltd., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Quest Diagnostics, Sema4 and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

How has the global carrier screening market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global carrier screening market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the medical condition?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global carrier screening market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Carrier Screening Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Expanded Carrier Screening
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 Customized Panel Testing
  - 6.1.2.2 Predesigned Panel Testing
- 6.1.3 Market Forecast
6.2 Targeted Disease Carrier Screening
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Medical Condition

7.1 Pulmonary Conditions
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Hematological Conditions
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Neurological Conditions
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Technology

8.1 DNA Sequencing
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Polymerase Chain Reaction
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Microarrays
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by End User

9.1 Hospitals and Clinics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Reference Laboratories
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Fulgent Genetics
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
- 15.3.2 Gene By Gene Ltd. (MyDNA)
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
- 15.3.3 Illumina Inc.
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Invitae Corporation
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
- 15.3.5 MedGenome Labs Ltd.
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
- 15.3.6 Myriad Genetics Inc.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Natera Inc.
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
- 15.3.8 OPKO Health Inc.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Quest Diagnostics
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Sema4
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
- 15.3.11 Thermo Fisher Scientific Inc.
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Carrier Screening Market: Major Drivers and Challenges
Figure 2: Global: Carrier Screening Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Carrier Screening Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Carrier Screening Market: Breakup by Type (in %), 2022
Figure 5: Global: Carrier Screening Market: Breakup by Medical Condition (in %), 2022
Figure 6: Global: Carrier Screening Market: Breakup by Technology (in %), 2022
Figure 7: Global: Carrier Screening Market: Breakup by End User (in %), 2022
Figure 8: Global: Carrier Screening Market: Breakup by Region (in %), 2022
Figure 9: Global: Carrier Screening (Expanded Carrier Screening) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Carrier Screening (Expanded Carrier Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Carrier Screening (Targeted Disease Carrier Screening) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Carrier Screening (Targeted Disease Carrier Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Carrier Screening (Pulmonary Conditions) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Carrier Screening (Pulmonary Conditions) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Carrier Screening (Hematological Conditions) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Carrier Screening (Hematological Conditions) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Carrier Screening (Neurological Conditions) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Carrier Screening (Neurological Conditions) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Carrier Screening (Other Medical Conditions) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Carrier Screening (Other Medical Conditions) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Carrier Screening (DNA Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Carrier Screening (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Carrier Screening (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Carrier Screening (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Carrier Screening (Microarrays) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Carrier Screening (Microarrays) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Carrier Screening (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Carrier Screening (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Carrier Screening (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Carrier Screening (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Carrier Screening (Reference Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Carrier Screening (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Carrier Screening (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Carrier Screening (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: North America: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: North America: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: United States: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: United States: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Canada: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Canada: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Asia-Pacific: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Asia-Pacific: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: China: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: China: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Japan: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Japan: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: India: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: India: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: South Korea: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: South Korea: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Australia: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Australia: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Indonesia: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Indonesia: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Others: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Others: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Europe: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Europe: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Germany: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Germany: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: France: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: France: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: United Kingdom: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: United Kingdom: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Italy: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Italy: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Spain: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Spain: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Russia: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Russia: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Others: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Others: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Latin America: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Latin America: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Brazil: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Brazil: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Mexico: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Mexico: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Others: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Others: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Middle East and Africa: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Middle East and Africa: Carrier Screening Market: Breakup by Country (in %), 2022
Figure 83: Middle East and Africa: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Global: Carrier Screening Industry: SWOT Analysis
Figure 85: Global: Carrier Screening Industry: Value Chain Analysis
Figure 86: Global: Carrier Screening Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Carrier Screening Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Carrier Screening Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Carrier Screening Market Forecast: Breakup by Medical Condition (in Million US$), 2023-2028
Table 4: Global: Carrier Screening Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 5: Global: Carrier Screening Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Carrier Screening Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Carrier Screening Market: Competitive Structure
Table 8: Global: Carrier Screening Market: Key Players

02-2729-4219

+886-2-2729-4219